CardioKinetix Obtains $14,500,000 Series C Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a207d59b-c9b9-4bff-8cfb-a74551d31b8f&Preview=1
Date 7/15/2008
Company Name CardioKinetix
Mailing Address 925 Hamilton Avenue Menlo Park, CA 94025
Company Description CardioKinetix, Inc. is developing new technology for treating Congestive Heart Failure (CHF). This is a catheter-based intervention implanted into the heart. CHF results from damage to the heart from several causes, which affects nearly five million people in the U.S.